<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN" "JATS-archivearticle1-3-mathml3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="1.3" xml:lang="en" article-type="research-article"><?properties manuscript?><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-journal-id">100892005</journal-id><journal-id journal-id-type="pubmed-jr-id">21821</journal-id><journal-id journal-id-type="nlm-ta">J Acquir Immune Defic Syndr</journal-id><journal-id journal-id-type="iso-abbrev">J Acquir Immune Defic Syndr</journal-id><journal-title-group><journal-title>Journal of acquired immune deficiency syndromes (1999)</journal-title></journal-title-group><issn pub-type="ppub">1525-4135</issn><issn pub-type="epub">1944-7884</issn></journal-meta><article-meta><article-id pub-id-type="pmid">40338701</article-id><article-id pub-id-type="pmc">12378994</article-id><article-id pub-id-type="doi">10.1097/QAI.0000000000003690</article-id><article-id pub-id-type="manuscript">HHSPA2106101</article-id><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title>Barriers to Rapid Enrollment and ART Initiation Among US HIV Care Facilities</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>O&#x02019;Shea</surname><given-names>Jesse</given-names></name><degrees>MD, MSc</degrees><xref rid="A1" ref-type="aff">a</xref></contrib><contrib contrib-type="author"><name><surname>Yuan</surname><given-names>Xin</given-names></name><degrees>MD, MSc</degrees><xref rid="A2" ref-type="aff">b</xref></contrib><contrib contrib-type="author"><name><surname>Lu</surname><given-names>Jen-Feng</given-names></name><degrees>MPH</degrees><xref rid="A2" ref-type="aff">b</xref></contrib><contrib contrib-type="author"><name><surname>Buchacz</surname><given-names>Kate</given-names></name><degrees>PhD</degrees><xref rid="A1" ref-type="aff">a</xref></contrib><contrib contrib-type="author"><name><surname>Iqbal</surname><given-names>Kashif</given-names></name><degrees>MPH</degrees><xref rid="A1" ref-type="aff">a</xref></contrib><contrib contrib-type="author"><name><surname>Johnston</surname><given-names>Marie</given-names></name><degrees>PharmD, MPH</degrees><xref rid="A1" ref-type="aff">a</xref></contrib><contrib contrib-type="author"><name><surname>Beer</surname><given-names>Linda</given-names></name><degrees>PhD</degrees><xref rid="A1" ref-type="aff">a</xref></contrib><contrib contrib-type="author"><name><surname>Weiser</surname><given-names>John</given-names></name><degrees>MD, MPH</degrees><xref rid="A1" ref-type="aff">a</xref></contrib></contrib-group><aff id="A1"><label>a</label>Division of HIV Prevention, Centers for Disease Control and Prevention, Atlanta, GA;</aff><aff id="A2"><label>b</label>DLH Corporation, Atlanta, GA.</aff><author-notes><corresp id="CR1">Correspondence to: Jesse O&#x02019;Shea, MD, MSc, CDC, Division of HIV Prevention, 1600 Clifton Road. MS E-45, Atlanta GA30329 (<email>kst4@cdc.gov</email>).</corresp></author-notes><pub-date pub-type="nihms-submitted"><day>21</day><month>8</month><year>2025</year></pub-date><pub-date pub-type="epub"><day>08</day><month>5</month><year>2025</year></pub-date><pub-date pub-type="pmc-release"><day>26</day><month>8</month><year>2025</year></pub-date><elocation-id>10.1097/QAI.0000000000003690</elocation-id><abstract id="ABS1"><sec id="S1"><title>Background:</title><p id="P1">Rapid linkage to HIV care and antiretroviral therapy (ART) initiation is now the standard of care for treating people with HIV. Understanding and intervening on barriers to rapid enrollment and ART initiation are needed to meet the goals of the Ending the HIV Epidemic in the US initiative.</p></sec><sec id="S2"><title>Methods:</title><p id="P2">We analyzed 2021 data from the Medical Monitoring Project on characteristics of 455 facilities providing care to a national probability sample of US People with HIV.</p></sec><sec id="S3"><title>Results:</title><p id="P3">Overall, only 19.9% (95% CI: 16.0% to 23.9%) of HIV facilities could routinely offer a first appointment in &#x0003c;1 business day (rapid enrollment). The most commonly reported barriers to rapid enrollment were insufficient provider capacity (56%), patient preference (50%), and patients lacking required documents (19%). The most commonly reported documents required for enrollment were positive HIV antibody or detectable viral load (52%), government-issued identification (36%), proof of residence (24%), and proof of income (22%). RWHAP-funded facilities more frequently required these documents than non&#x02013;RWHAP-funded facilities. Most facilities (73%) were routinely able to obtain a 30-day supply of ART during the first HIV care provider visit (rapid ART initiation). The most commonly reported barriers to rapid ART included unavailable test results (56%), delays in getting medication paid for (49%), unavailable starter packs (36%), inability to afford copayment (31%), and patient preference (29%).</p></sec><sec id="S4"><title>Conclusion:</title><p id="P4">Structural, provider-related, or patient-level barriers may delay rapid clinic enrollment or ART initiation. HIV care programs can benefit from removing barriers to care, easing requirements for clinical enrollment and ART prescriptions, and improving patient readiness.</p></sec></abstract><kwd-group><kwd>rapid start</kwd><kwd>clinic enrollment</kwd><kwd>HIV</kwd><kwd>antiretroviral therapy</kwd></kwd-group></article-meta></front><body><sec id="S5"><title>BACKGROUND</title><p id="P5">To achieve the Ending the HIV Epidemic in the US (EHE) initiative goal of reducing new HIV infections in the United States by 90% by 2030, people with HIV (PWH) need to have a diagnosis as early as possible and be treated with antiretroviral therapy (ART) rapidly and effectively to have sustained viral suppression.<sup><xref rid="R1" ref-type="bibr">1</xref>,<xref rid="R2" ref-type="bibr">2</xref></sup> Rapid initiation of ART, ideally on the same day as HIV diagnosis or return to care, offers immediate access to HIV medical care.<sup><xref rid="R3" ref-type="bibr">3</xref>&#x02013;<xref rid="R6" ref-type="bibr">6</xref></sup> Rapid ART reduces the time to viral suppression and improves morbidity and mortality in PWH.<sup><xref rid="R3" ref-type="bibr">3</xref>&#x02013;<xref rid="R5" ref-type="bibr">5</xref></sup> Delays in initiating ART are associated with subsequent lower rates of viral suppression and retention in care, and with earlier development of first AIDS event.<sup><xref rid="R5" ref-type="bibr">5</xref></sup></p><p id="P6">The Ryan White HIV/AIDS Program (RWHAP) is a federally funded program providing a comprehensive system of HIV primary medical care, essential support services, and medications for low-income PWH who are uninsured and underserved.<sup><xref rid="R7" ref-type="bibr">7</xref></sup> For the past 30 years, the RWHAP has had an important role in the national public health response to HIV&#x02014;more than half of adults with diagnosed HIV rely on the program.<sup><xref rid="R8" ref-type="bibr">8</xref>,<xref rid="R9" ref-type="bibr">9</xref></sup> However, RWHAP may have specific eligibility requirements and considerations that can affect clinic enrollment and ART initiation processes.</p><p id="P7">Rapid linkage to HIV care and ART initiation is now the standard of care for treating PWH and is a key strategy of EHE.<sup><xref rid="R1" ref-type="bibr">1</xref>&#x02013;<xref rid="R6" ref-type="bibr">6</xref></sup> Structural, provider-related, and patient-level barriers may impede rapid clinic enrollment and initiation of ART. Understanding and addressing these barriers is essential to meet the goals of EHE. In this study, we examined the availability of, and barriers to, rapid enrollment and ART initiation among HIV care facilities attended by a representative sample of PWH in the United States, overall and by RWHAP funding status of facilities.</p></sec><sec id="S6"><title>METHODS</title><p id="P8">The Medical Monitoring Project (MMP) is a two-stage complex sample survey that produces nationally representative estimates of US adults with diagnosed HIV.<sup><xref rid="R10" ref-type="bibr">10</xref></sup> We analyzed MMP Facility Survey data collected 07/2021&#x02013;11/2021 on characteristics of 455 facilities providing care to MMP 2019 cycle respondents (response rate, 45%).<sup><xref rid="R11" ref-type="bibr">11</xref></sup> Participating facility characteristics and survey administration methods have been described elsewhere.<sup><xref rid="R11" ref-type="bibr">11</xref></sup> Data were weighted based on weighting classes informed by a nonresponse analysis to reduce nonresponse bias in facility-level estimates. Facility data on the number of business days needed to offer an appointment to patients who are new to the facility, availability of and barriers to rapid enrollment and ART initiation, and facility characteristics, including RWHAP funding, were collected. Time to enrollment was defined as the number of business days from an initial request by patients who are new to the facility until an appointment with an HIV care provider is routinely offered. Rapid enrollment was defined as &#x02264;1 business day. Rapid ART initiation was defined as routinely being able to provide a 30-day supply of ART at the first HIV care provider visit. The term provider refers to a health care professional with prescribing privileges authorized by the state. See <xref rid="SD1" ref-type="supplementary-material">Appendix 1</xref> for relevant survey questions, <xref rid="SD1" ref-type="supplementary-material">Supplemental Digital Content</xref>, <ext-link xlink:href="http://links.lww.com/QAI/C508" ext-link-type="uri">http://links.lww.com/QAI/C508</ext-link>. We generated weighted percentages with 95% confidence intervals (CI) of facility characteristics. We assessed significant (<italic toggle="yes">P</italic> &#x0003c; 0.05) differences in characteristics of facilities by RWHAP funding status using Rao&#x02013;Scott &#x003c7;<sup>2</sup> tests.</p></sec><sec id="S7"><title>RESULTS</title><sec id="S8"><title>Rapid Enrollment and ART Initiation</title><p id="P9">Overall, 19.9% (95% CI: 16.0% to 23.9%) of HIV facilities could routinely offer a first appointment in &#x02264;1 business day (rapid enrollment; data not displayed in tables). However, a larger proportion of HIV facilities could routinely offer a first appointment in 2&#x02013;9 business days (48.4%; 95% CI: 43.4% to 53.4%). Nearly a third of facilities (31.6%; 95% CI: 27.0% to 36.3%) routinely offered new patients an appointment in &#x02265;10 business days. The median business days to offer a first appointment was 4.8 (95% CI: 4.0% to 5.6%) days. Most facilities (73%) reported that all patients were routinely able to obtain a 30-day supply of ART on the day of the first HIV care provider visit (rapid ART initiation).</p></sec><sec id="S9"><title>Barriers to Rapid Enrollment</title><p id="P11">The most commonly reported barriers to rapid enrollment were insufficient provider capacity (56%), patient preference (50%), and patients lacking required documents (19%) (<xref rid="T1" ref-type="table">Table 1</xref>). For facilities that routinely offered an appointment within &#x02264;1 business day (rapid enrollment), the most common barriers cited were patient preference (65%), insufficient provider capacity (24%), and patients lacking documents for facility enrollment (17%). For facilities offering appointments within 2&#x02013;9 business days, the most common barriers cited were patient preference (56%), insufficient provider capacity (52%), and patients lacking documents for facility enrollment (20%). For facilities offering appointments in 10 or more business days, the most common barriers cited were insufficient provider capacity (77%), patient preference (37%), and patients lacking documents for facility enrollment (18%).</p><p id="P12">Facilities reported requiring the following documents for scheduling the first appointment: positive HIV antibody or detectable viral load (52%), government-issued identification (36%), proof of residence (24%), proof of income (22%), a CD4 lymphocyte count result (19%), and the result of a test for tuberculosis (6%) (<xref rid="T1" ref-type="table">Table 1</xref>). Overall, 32% of facilities did not require any of these documents, including 44%, 33%, and 23% of facilities routinely offering a first appointment within &#x02264;1, 2&#x02013;9, and &#x02265;10 business days, respectively.</p></sec><sec id="S10"><title>Barriers to Rapid ART Initiation</title><p id="P13">Overall, the most commonly reported barriers to obtaining a 30-day supply of ART at the first HIV care provider visit included unavailable test results (56%), delays in getting medication paid for (49%), unavailable starter packs (36%), patient cannot afford copayment (31%), and patient preference (29%) (<xref rid="T2" ref-type="table">Table 2</xref>).</p><p id="P14">Other administrative barriers to obtaining a 30-day supply of ART at the first HIV care provider visit included provider not committed to rapid ART (12%), lack of standardized protocol for clinicians to follow (10%), lack of trained staff to submit patient assistance program applications (9%), and facility administration is not committed to rapid ART (4%). Approximately 77.8% (95% CI: 71.5%&#x02212;84.2%) of facilities with an on-site pharmacy were able to offer a 30-day supply of ART to all patients at the first visit, compared with 68.8% (95% CI: 61.9%&#x02212;75.7%) without an on-site pharmacy (data not displayed in tables).</p></sec><sec id="S11"><title>Differences by RWHAP Funding Status</title><p id="P15">In this analysis, 43% of facilities reported receiving RWHAP funding (<xref rid="T1" ref-type="table">Table 1</xref>). There were no significant differences in the prevalence of being able to provide rapid enrollment and ART initiation between RWHAP-funded and nonfunded facilities (data not displayed in tables). However, the prevalence of barriers to rapid enrollment differed by RWHAP funding status. Higher percentages of RWHAP-funded facilities reported patient preference (59% vs. 44%, <italic toggle="yes">P</italic> = 0.003), and lower percentages reported insufficient provider capacity (48% vs. 62%, <italic toggle="yes">P</italic> = 0.005) as barriers to rapid enrollment. A higher percentage of RWHAP-funded facilities required proof of income (42% vs. 6%), proof of residence (43% vs. 9%), and government-issued ID (42% vs 31%) for the first appointment (all <italic toggle="yes">P</italic>-values &#x0003c;0.05). A higher percentage of non&#x02013;RWHAP-funded clinics did not require any of these documents (41% vs. 21%, <italic toggle="yes">P</italic> &#x0003c;0.0001). A higher percentage of non&#x02013;RWHAP-funded facilities reported patients unable to afford copayments (38% vs. 17%; <italic toggle="yes">P</italic> &#x0003c; 0.05) as a barrier to providing 30 days of ART at the first visit.</p></sec></sec><sec id="S12"><title>DISCUSSION</title><p id="P16">Among HIV care facilities providing care to a nationally representative sample of US PWH, we documented the availability of and barriers to rapid enrollment and ART initiation, which are key strategies of Ending the HIV Epidemic in the United States. Only 1 in 5 facilities could routinely enroll patients with a first appointment in &#x02264;1 day. However, 73% of facilities reported all patients were routinely able to obtain a 30-day supply of ART on the day of their first HIV care provider visit. Structural, provider-related, or patient-level barriers may delay rapid enrollment or ART initiation. HIV care programs can benefit from removing barriers to care, easing requirements for clinical enrollment and ART prescriptions, and improving patient readiness.</p><p id="P17">Although rapid clinic enrollment is a crucial component of efforts to reduce the time from HIV diagnosis to viral suppression, only 20% of HIV facilities were able to provide rapid enrollment. Insufficient provider capacity was a major barrier to rapid enrollment. Studies have highlighted gaps between the current HIV workforce and the demand for HIV services, along with high dissatisfaction among HIV care providers regarding remuneration and administrative tasks.<sup><xref rid="R11" ref-type="bibr">11</xref>&#x02013;<xref rid="R13" ref-type="bibr">13</xref></sup> To address this HIV workforce shortage, strategies such as establishing a broad base of clinicians serving fewer patients and recruiting/training non-HIV primary care providers have been proposed.<sup><xref rid="R14" ref-type="bibr">14</xref></sup> In addition, task shifting and care models that prioritize patients with higher medical needs and newly diagnosed individuals are also potential solutions.<sup><xref rid="R15" ref-type="bibr">15</xref>&#x02013;<xref rid="R17" ref-type="bibr">17</xref></sup> Likewise, improved care coordination in Federally Qualified Health Centers has shown promise in addressing provider capacity issues.<sup><xref rid="R11" ref-type="bibr">11</xref>,<xref rid="R18" ref-type="bibr">18</xref></sup></p><p id="P18">Many facilities require certain documents, generally related to establishing benefits in order for services to be covered (such as proof of income or residence), before scheduling or offering an appointment for clinic enrollment. Notably, RWHAP-funded facilities mandate more documents for scheduling the first appointment, which may hinder rapid enrollment and ART initiation. We also found that requiring diagnostic or confirmatory HIV test results could be a barrier to both rapid clinic enrollment and ART initiation. These concerns or policies may stem from past experiences when ART had higher toxicity and testing methods were less precise.<sup><xref rid="R19" ref-type="bibr">19</xref>,<xref rid="R20" ref-type="bibr">20</xref></sup> To expedite care, successful interventions have involved easing document requirements and expanding eligibility (eg, presumptive RWHAP eligibility) for rapid enrollment.<sup><xref rid="R16" ref-type="bibr">16</xref></sup> Other streamlining efforts include dedicated open scheduling slots specifically for patients starting ART and not mandating baseline laboratory tests before an appointment or ART initiation.<sup><xref rid="R6" ref-type="bibr">6</xref>,<xref rid="R21" ref-type="bibr">21</xref></sup></p><p id="P19">Our findings show that patient&#x02014;and, to a lesser extent, provider&#x02014;concerns about rapid enrollment and ART initiation are prevalent. Patient preference was a frequently reported barrier to both rapid clinic enrollment and ART initiation. Concerns about side effects, mistrust of medications/providers, impact on quality of life, HIV stigma, discrimination, and preference for alternative medicine/self-care are linked to lower ART acceptance in patients already receiving HIV care.<sup><xref rid="R22" ref-type="bibr">22</xref>&#x02013;<xref rid="R24" ref-type="bibr">24</xref></sup> Patient&#x02013;provider communication that reinforces respect, trust, and HIV treatment literacy, along with convenient multipurpose HIV care facilities and personalized treatment plans addressing possible diagnosis denial, are essential for optimizing engagement.<sup><xref rid="R25" ref-type="bibr">25</xref>,<xref rid="R26" ref-type="bibr">26</xref></sup></p><p id="P20">Provider knowledge, attitudes, and beliefs about rapid ART initiation vary. Many providers adhere to &#x0201c;traditional&#x0201d; views of readiness (eg, insufficient time to adjust to an HIV diagnosis), which in turn influences perceived patient willingness to start treatment.<sup><xref rid="R19" ref-type="bibr">19</xref>,<xref rid="R27" ref-type="bibr">27</xref></sup> Furthermore, provider views on readiness differ based on patient characteristics, potentially leading to disparities if certain groups are not considered ready for treatment.<sup><xref rid="R19" ref-type="bibr">19</xref></sup> Our data reveal that a minority of facilities report providers (12%) or facility administration (4%) not being fully committed to immediate ART initiation. Other surveys also support this by indicating provider apprehension toward rapid ART initiation because of ART resistance and effectiveness concerns.<sup><xref rid="R16" ref-type="bibr">16</xref>,<xref rid="R28" ref-type="bibr">28</xref></sup></p><p id="P21">To improve perceived readiness among both patients and providers, exploring shared decision-making and providing education for both parties are crucial areas of focus. Patients may not be fully prepared for ART initiation before their first visit date. Since Rapid ART initiation is now the standard of care, clinics, programs, and providers should have personnel available to offer ART promptly while also being attentive to patients&#x02019; preferences and needs. Training initiatives, such as those provided by AIDS Education Training Centers and Centers for Disease Control and Prevention&#x02019;s Capacity Building Assistance programs, have demonstrated some success in increasing the quality of care provided to PWH.<sup><xref rid="R16" ref-type="bibr">16</xref>,<xref rid="R29" ref-type="bibr">29</xref>&#x02013;<xref rid="R31" ref-type="bibr">31</xref></sup> Enhancing and expanding patient-centered initiatives focused on the benefits of rapid ART initiation, along with increasing provider participation in these efforts, may help improve rapid ART knowledge and beliefs.</p><p id="P22">Some limitations of this analysis include low facility survey response rate, although we minimized potential bias by weighting the data based on information known for all facilities. Because patients did not complete facility surveys, barriers such as patient readiness were measured from the facility perspective, and some terms that were not defined were subject to interpretation from the facility. Patient-level information, including diagnosis date, was unavailable for this study, preventing the calculation of key metrics such as the time from diagnosis to the first appointment and ART initiation. In addition, individual outcomes and sociodemographic factors associated with ART receipt and care were not reported here but have been published by the MMP.<sup><xref rid="R32" ref-type="bibr">32</xref></sup> Facilities adapt varying ancillary services to overcome barriers to care. The survey did not measure the implementation of reported practices, nor was the quality of implemented practices assessed. Facility patients&#x02019; perspectives on the availability of services and their quality may differ from those of facility staff.<sup><xref rid="R33" ref-type="bibr">33</xref>,<xref rid="R34" ref-type="bibr">34</xref></sup> Finally, social desirability bias in reporting on facility practices might have affected our estimates.</p><p id="P23">The barriers reported in this analysis are similar to those in prior studies.<sup><xref rid="R16" ref-type="bibr">16</xref>,<xref rid="R19" ref-type="bibr">19</xref></sup> Future analyses should consider individual-level variables such as housing instability, stigma, and medical mistrust to better understand their impact on rapid enrollment and ART initiation. Structural, provider-related, or patient-level barriers may delay rapid clinic enrollment or ART initiation. To ensure the success of rapid ART programs, health systems must streamline bureaucratic processes, reduce structural barriers, increase the HIV workforce, and improve patient/provider readiness to initiate ART rapidly.</p></sec><sec sec-type="supplementary-material" id="SM1"><title>Supplementary Material</title><supplementary-material id="SD1" position="float" content-type="local-data"><label>Supplemental Material</label><media xlink:href="NIHMS2106101-supplement-Supplemental_Material.docx" id="d67e401" position="anchor"/></supplementary-material><p id="P26">Supplemental digital content is available for this article. Direct URL citations appear in the printed text and are provided in the HTML and PDF versions of this article on the journal&#x02019;s Web site (<ext-link xlink:href="http://www.jaids.com/" ext-link-type="uri">www.jaids.com</ext-link>).</p></sec></body><back><ack id="S13"><p id="P24">Funding for the Medical Monitoring Project is provided by the Centers for Disease Control and Prevention.</p><p id="P25">The authors have no funding or conflicts of interest to disclose.</p></ack><fn-group><fn id="FN1"><p id="P27">The findings and conclusions in this report are those of the authors and do not necessarily represent the official position of the Centers for Disease Control and Prevention.</p></fn></fn-group><ref-list><title>REFERENCES</title><ref id="R1"><label>1.</label><mixed-citation publication-type="journal"><name><surname>Fauci</surname><given-names>AS</given-names></name>, <name><surname>Redfield</surname><given-names>RR</given-names></name>, <name><surname>Sigounas</surname><given-names>G</given-names></name>, <etal/>
<article-title>Ending the HIV epidemic: a plan for the United States</article-title>. <source>JAMA</source>. <year>2019</year>;<volume>321</volume>:<fpage>844</fpage>&#x02013;<lpage>845</lpage>. doi.<pub-id pub-id-type="pmid">30730529</pub-id>
</mixed-citation></ref><ref id="R2"><label>2.</label><mixed-citation publication-type="journal"><name><surname>Marston</surname><given-names>HD</given-names></name>, <name><surname>Dieffenbach</surname><given-names>CW</given-names></name>, <name><surname>Fauci</surname><given-names>AS</given-names></name>. <article-title>Ending the HIV epidemic in the United States: closing the implementation gaps</article-title>. <source>Ann Intern Med</source>. <year>2018</year>;<volume>169</volume>:<fpage>411</fpage>&#x02013;<lpage>412</lpage>.<pub-id pub-id-type="pmid">30140920</pub-id>
</mixed-citation></ref><ref id="R3"><label>3.</label><mixed-citation publication-type="journal"><name><surname>Koenig</surname><given-names>SP</given-names></name>, <name><surname>Dorvil</surname><given-names>N</given-names></name>, <name><surname>D&#x000e9;vieux</surname><given-names>JG</given-names></name>, <etal/>
<article-title>Same-day HIV testing with initiation of antiretroviral therapy versus standard care for persons living with HIV: a randomized unblinded trial</article-title>. <source>Plos Med</source>. <year>2017</year>;<volume>14</volume>:<fpage>e1002357</fpage>.<pub-id pub-id-type="pmid">28742880</pub-id>
</mixed-citation></ref><ref id="R4"><label>4.</label><mixed-citation publication-type="journal"><name><surname>Coffey</surname><given-names>S</given-names></name>, <name><surname>Bacchetti</surname><given-names>P</given-names></name>, <name><surname>Sachdev</surname><given-names>D</given-names></name>, <etal/>
<article-title>Rapid antiretroviral therapy: high virologic suppression rates with immediate antiretroviral therapy initiation in a vulnerable urban clinic population</article-title>. <source>AIDS</source>. <year>2019</year>;<volume>33</volume>:<fpage>825</fpage>&#x02013;<lpage>832</lpage>.<pub-id pub-id-type="pmid">30882490</pub-id>
</mixed-citation></ref><ref id="R5"><label>5.</label><mixed-citation publication-type="journal"><name><surname>Mateo-Urdiales</surname><given-names>A</given-names></name>, <name><surname>Johnson</surname><given-names>S</given-names></name>, <name><surname>Smith</surname><given-names>R</given-names></name>, <etal/>
<article-title>Rapid initiation of antiretroviral therapy for people living with HIV</article-title>. <source>Cochrane Database Syst Rev</source>. <year>2019</year>;<volume>6</volume>:<fpage>CD012962</fpage>.<pub-id pub-id-type="pmid">31206168</pub-id>
</mixed-citation></ref><ref id="R6"><label>6.</label><mixed-citation publication-type="journal"><name><surname>Colasanti</surname><given-names>J</given-names></name>, <name><surname>Sumitani</surname><given-names>J</given-names></name>, <name><surname>Mehta</surname><given-names>CC</given-names></name>, <etal/>
<article-title>Implementation of a rapid entry program decreases time to viral suppression among vulnerable persons living with HIV in the southern United States</article-title>. <source>Open Forum Infect Dis</source>. <year>2018</year>;<volume>5</volume>:<fpage>ofy104</fpage>.<pub-id pub-id-type="pmid">29992172</pub-id>
</mixed-citation></ref><ref id="R7"><label>7.</label><mixed-citation publication-type="webpage"><collab>Health Resources and Services Administration</collab>. <source>Ryan White HIV/AIDS Program</source>; <year>2024</year>. <ext-link xlink:href="https://ryanwhite.hrsa.gov/" ext-link-type="uri">https://ryanwhite.hrsa.gov/</ext-link></mixed-citation></ref><ref id="R8"><label>8.</label><mixed-citation publication-type="webpage"><collab>Health Resources and Services Administration</collab>. <source>Ryan white HIV/AIDS program annual data report</source>
<year>2022</year>. Available at: <ext-link xlink:href="https://ryanwhite.hrsa.gov/sites/default/files/ryanwhite/data/rwhap-annual-client-level-data-report-2022.pdf" ext-link-type="uri">https://ryanwhite.hrsa.gov/sites/default/files/ryanwhite/data/rwhap-annual-client-level-data-report-2022.pdf</ext-link>. Accessed <date-in-citation>September 18, 2024</date-in-citation>.</mixed-citation></ref><ref id="R9"><label>9.</label><mixed-citation publication-type="journal"><name><surname>Mandsager</surname><given-names>P</given-names></name>, <name><surname>Marier</surname><given-names>A</given-names></name>, <name><surname>Cohen</surname><given-names>S</given-names></name>, <etal/>
<article-title>Reducing HIV-related health disparities in the health resources and services administration&#x02019;s Ryan White HIV/AIDS program</article-title>. <source>Am J Public Health</source>. <year>2018</year>;<volume>108</volume>:<fpage>S246</fpage>&#x02013;<lpage>S250</lpage>.<pub-id pub-id-type="pmid">30383416</pub-id>
</mixed-citation></ref><ref id="R10"><label>10.</label><mixed-citation publication-type="journal"><name><surname>Beer</surname><given-names>L</given-names></name>, <name><surname>Johnson</surname><given-names>CH</given-names></name>, <name><surname>Fagan</surname><given-names>JL</given-names></name>, <etal/>
<article-title>A national behavioral and clinical surveillance system of adults with diagnosed HIV (the medical monitoring Project): protocol for an annual cross-sectional interview and medical record abstraction survey</article-title>. <source>JMIR Res Protoc</source>. <year>2019</year>;<volume>8</volume>:<fpage>e15453</fpage>. doi.<pub-id pub-id-type="pmid">31738178</pub-id>
</mixed-citation></ref><ref id="R11"><label>11.</label><mixed-citation publication-type="journal"><name><surname>Beer</surname><given-names>L</given-names></name>, <name><surname>Williams</surname><given-names>D</given-names></name>, <name><surname>Tie</surname><given-names>Y</given-names></name>, <etal/>
<article-title>The capacity of HIV care facilities to implement strategies recommended by the ending the HIV epidemic initiative: the Medical Monitoring Project facility survey</article-title>. <source>J Acquir Immune Defic Syndr</source>. <year>2023</year>;<volume>94</volume>:<fpage>290</fpage>&#x02013;<lpage>300</lpage>.<pub-id pub-id-type="pmid">37643411</pub-id>
</mixed-citation></ref><ref id="R12"><label>12.</label><mixed-citation publication-type="journal"><name><surname>Weiser</surname><given-names>J</given-names></name>, <name><surname>Chen</surname><given-names>G</given-names></name>, <name><surname>Beer</surname><given-names>L</given-names></name>, <etal/>
<article-title>Sustaining the HIV care provider workforce: Medical Monitoring Project HIV provider survey, 2013&#x02013;2014</article-title>. <source>Health Serv Res</source>. <year>2019</year>;<volume>54</volume>:<fpage>1065</fpage>&#x02013;<lpage>1074</lpage>.<pub-id pub-id-type="pmid">31264205</pub-id>
</mixed-citation></ref><ref id="R13"><label>13.</label><mixed-citation publication-type="journal"><name><surname>Weiser</surname><given-names>J</given-names></name>, <name><surname>Beer</surname><given-names>L</given-names></name>, <name><surname>West</surname><given-names>BT</given-names></name>, <etal/>
<article-title>Qualifications, demographics, satisfaction, and future capacity of the HIV care provider workforce in the United States, 2013&#x02013;2014</article-title>. <source>Clin Infect Dis</source>. <year>2016</year>;<volume>63</volume>:<fpage>966</fpage>&#x02013;<lpage>975</lpage>.<pub-id pub-id-type="pmid">27358352</pub-id>
</mixed-citation></ref><ref id="R14"><label>14.</label><mixed-citation publication-type="journal"><name><surname>Armstrong</surname><given-names>WS</given-names></name>. <article-title>The human immunodeficiency virus workforce in crisis: an urgent need to build the foundation required to end the epidemic</article-title>. <source>Clin Infect Dis</source>. <year>2021</year>;<volume>72</volume>:<fpage>1627</fpage>&#x02013;<lpage>1630</lpage>.<pub-id pub-id-type="pmid">32211784</pub-id>
</mixed-citation></ref><ref id="R15"><label>15.</label><mixed-citation publication-type="journal"><name><surname>El-Sadr</surname><given-names>WM</given-names></name>, <name><surname>Harripersaud</surname><given-names>K</given-names></name>, <name><surname>Rabkin</surname><given-names>M</given-names></name>. <article-title>Reaching global HIV/AIDS goals: what got us here, won&#x02019;t get us there</article-title>. <source>PLos Med</source>. <year>2017</year>;<volume>14</volume>: <fpage>e1002421</fpage>.<pub-id pub-id-type="pmid">29112691</pub-id>
</mixed-citation></ref><ref id="R16"><label>16.</label><mixed-citation publication-type="journal"><name><surname>Pettit</surname><given-names>AC</given-names></name>, <name><surname>Pichon</surname><given-names>LC</given-names></name>, <name><surname>Ahonkhai</surname><given-names>AA</given-names></name>, <etal/>
<article-title>Comprehensive process mapping and qualitative interviews to inform implementation of rapid linkage to HIV care programs in a mid-sized urban setting in the southern United States</article-title>. <source>J Acquir Immune Defic Syndr</source>. <year>2022</year>;<volume>90</volume>:<fpage>S56</fpage>&#x02013;<lpage>S64</lpage>.<pub-id pub-id-type="pmid">35703756</pub-id>
</mixed-citation></ref><ref id="R17"><label>17.</label><mixed-citation publication-type="journal"><name><surname>Roy</surname><given-names>M</given-names></name>, <name><surname>Bolton Moore</surname><given-names>C</given-names></name>, <name><surname>Sikazwe</surname><given-names>I</given-names></name>, <etal/>
<article-title>A review of differentiated service delivery for HIV treatment: effectiveness, mechanisms, targeting, and scale</article-title>. <source>Curr HIV/AIDS Rep</source>. <year>2019</year>;<volume>16</volume>:<fpage>324</fpage>&#x02013;<lpage>334</lpage>. doi.<pub-id pub-id-type="pmid">31230342</pub-id>
</mixed-citation></ref><ref id="R18"><label>18.</label><mixed-citation publication-type="journal"><name><surname>Levine</surname><given-names>L</given-names></name>, <name><surname>Fuller</surname><given-names>SM</given-names></name>, <name><surname>Koester</surname><given-names>K</given-names></name>. <article-title>Interventions to build capacity of the HIV healthcare workforce: lessons learned from practice transformation projects in California</article-title>. In: <source>Northern California HIV/AIDS Policy Research Center</source>; <year>2019</year>.</mixed-citation></ref><ref id="R19"><label>19.</label><mixed-citation publication-type="journal"><name><surname>Bertolino</surname><given-names>D</given-names></name>, <name><surname>Baim-Lance</surname><given-names>A</given-names></name>, <name><surname>D&#x02019;Aquila</surname><given-names>E</given-names></name>, <etal/>
<article-title>Immediate initiation of antiretroviral treatment: knowledge, attitudes, and practices among clinic staff in New York City</article-title>. <source>BMC Health Serv Res</source>. <year>2023</year>;<volume>23</volume>:<fpage>1039</fpage>.<pub-id pub-id-type="pmid">37770939</pub-id>
</mixed-citation></ref><ref id="R20"><label>20.</label><mixed-citation publication-type="journal"><name><surname>Hurt</surname><given-names>CB</given-names></name>, <name><surname>Nelson</surname><given-names>JAE</given-names></name>, <name><surname>Hightow-Weidman</surname><given-names>LB</given-names></name>, <etal/>
<article-title>Selecting an HIV test: a narrative review for clinicians and researchers</article-title>. <source>Sex Transm Dis</source>. <year>2017</year>;<volume>44</volume>:<fpage>739</fpage>&#x02013;<lpage>746</lpage>.<pub-id pub-id-type="pmid">29140890</pub-id>
</mixed-citation></ref><ref id="R21"><label>21.</label><mixed-citation publication-type="journal"><name><surname>Ruria</surname><given-names>EC</given-names></name>, <name><surname>Masaba</surname><given-names>R</given-names></name>, <name><surname>Kose</surname><given-names>J</given-names></name>, <etal/>
<article-title>Optimizing linkage to care and initiation and retention on treatment of adolescents with newly diagnosed HIV infection</article-title>. <source>AIDS</source>. <year>2017</year>;<volume>31</volume>(<issue>suppl 3</issue>):<fpage>S253</fpage>&#x02013;<lpage>S260</lpage>.<pub-id pub-id-type="pmid">28665883</pub-id>
</mixed-citation></ref><ref id="R22"><label>22.</label><mixed-citation publication-type="journal"><name><surname>Mgbere</surname><given-names>O</given-names></name>, <name><surname>Rodriguez-Barradas</surname><given-names>M</given-names></name>, <name><surname>Vigil</surname><given-names>KJ</given-names></name>, <etal/>
<article-title>Systemic delays in the initiation of antiretroviral therapy for clinically eligible HIV-infected patients in Houston, Texas: the providers&#x02019; report card</article-title>. <source>J Int Assoc Provid AIDS Care</source>. <year>2018</year>;<volume>17</volume>:<fpage>2325958218774042</fpage>. doi.<pub-id pub-id-type="pmid">29745311</pub-id>
</mixed-citation></ref><ref id="R23"><label>23.</label><mixed-citation publication-type="journal"><name><surname>Gwadz</surname><given-names>M</given-names></name>, <name><surname>Applegate</surname><given-names>E</given-names></name>, <name><surname>Cleland</surname><given-names>C</given-names></name>, <etal/>
<article-title>HIV-infected individuals who delay, decline, or discontinue antiretroviral therapy: comparing clinic-and peer-recruited cohorts</article-title>. <source>Front Public Health</source>. <year>2014</year>;<volume>2</volume>:<fpage>81</fpage>.<pub-id pub-id-type="pmid">25077137</pub-id>
</mixed-citation></ref><ref id="R24"><label>24.</label><mixed-citation publication-type="journal"><name><surname>Bofill</surname><given-names>LM</given-names></name>, <name><surname>Lopez</surname><given-names>M</given-names></name>, <name><surname>Dorigo</surname><given-names>A</given-names></name>, <etal/>
<article-title>Patient-provider perceptions on engagement in HIV care in Argentina</article-title>. <source>AIDS Care</source>. <year>2014</year>;<volume>26</volume>:<fpage>602</fpage>&#x02013;<lpage>607</lpage>.<pub-id pub-id-type="pmid">24138788</pub-id>
</mixed-citation></ref><ref id="R25"><label>25.</label><mixed-citation publication-type="journal"><name><surname>Carey</surname><given-names>JW</given-names></name>, <name><surname>Carnes</surname><given-names>N</given-names></name>, <name><surname>Schoua-Glusberg</surname><given-names>A</given-names></name>, <etal/>
<article-title>Barriers and facilitators for clinical care engagement among HIV-positive African American and Latino men who have sex with men</article-title>. <source>AIDS Patient Care STDS</source>. <year>2018</year>;<volume>32</volume>:<fpage>191</fpage>&#x02013;<lpage>201</lpage>. doi.<pub-id pub-id-type="pmid">29668307</pub-id>
</mixed-citation></ref><ref id="R26"><label>26.</label><mixed-citation publication-type="journal"><name><surname>Carey</surname><given-names>JW</given-names></name>, <name><surname>Carnes</surname><given-names>N</given-names></name>, <name><surname>Schoua-Glusberg</surname><given-names>A</given-names></name>, <etal/>
<article-title>Barriers and facilitators for antiretroviral treatment adherence among HIV-positive African American and Latino men who have sex with men</article-title>. <source>AIDS Educ Prev</source>. <year>2019</year>;<volume>31</volume>:<fpage>306</fpage>&#x02013;<lpage>324</lpage>.<pub-id pub-id-type="pmid">31361514</pub-id>
</mixed-citation></ref><ref id="R27"><label>27.</label><mixed-citation publication-type="book"><name><surname>Thornhill</surname><given-names>J</given-names></name>, <name><surname>Flanagan</surname><given-names>S</given-names></name>, <name><surname>Moir</surname><given-names>K</given-names></name>, <etal/>
<part-title>The East London immediate ART (ELIA) survey-attitudes &#x00026; barriers to immediate ART initiation</part-title>. <source>HIV Medicine</source>. <publisher-loc>NJ, USA</publisher-loc>: <publisher-name>WILEY</publisher-name>; <volume>111</volume>:<fpage>16</fpage>&#x02013;<lpage>75</lpage>; <ext-link xlink:href="https://onlinelibrary.wiley.com/doi/10.1111/hiv.12739" ext-link-type="uri">https://onlinelibrary.wiley.com/doi/10.1111/hiv.12739</ext-link> (<year>2019</year>).</mixed-citation></ref><ref id="R28"><label>28.</label><mixed-citation publication-type="journal"><name><surname>Weiser</surname><given-names>J</given-names></name>, <name><surname>Brooks</surname><given-names>JT</given-names></name>, <name><surname>Skarbinski</surname><given-names>J</given-names></name>, <etal/>
<article-title>Barriers to universal prescribing of antiretroviral therapy by HIV care providers in the United States, 2013&#x02013;2014</article-title>. <source>J Acquir Immune Defic Syndr</source>. <year>2017</year>;<volume>74</volume>:<fpage>479</fpage>&#x02013;<lpage>487</lpage>.<pub-id pub-id-type="pmid">28002186</pub-id>
</mixed-citation></ref><ref id="R29"><label>29.</label><mixed-citation publication-type="journal"><name><surname>Cook</surname><given-names>PF</given-names></name>, <name><surname>Friedman</surname><given-names>R</given-names></name>, <name><surname>Lord</surname><given-names>A</given-names></name>, <etal/>
<article-title>Outcomes of multimodal training for healthcare professionals at an AIDS education and training center</article-title>. <source>Eval Health Prof</source>. <year>2009</year>;<volume>32</volume>:<fpage>3</fpage>&#x02013;<lpage>22</lpage>.<pub-id pub-id-type="pmid">19131377</pub-id>
</mixed-citation></ref><ref id="R30"><label>30.</label><mixed-citation publication-type="journal"><name><surname>Khamarko</surname><given-names>K</given-names></name>, <name><surname>Kang Dufour</surname><given-names>MS</given-names></name>, <name><surname>Bodach</surname><given-names>S</given-names></name>, <etal/>
<article-title>Impact of AIDS education and training Centers on the US HIV medical workforce</article-title>. <source>Am J Public Health</source>. <year>2016</year>;<volume>106</volume>:<fpage>2190</fpage>&#x02013;<lpage>2193</lpage>.<pub-id pub-id-type="pmid">27736204</pub-id>
</mixed-citation></ref><ref id="R31"><label>31.</label><mixed-citation publication-type="webpage"><collab>Centers for Disease Control and Prevention</collab>. <source>Capacity building assistance</source>. Available at: <ext-link xlink:href="https://www.cdc.gov/hiv/capacity-building-assistance/" ext-link-type="uri">https://www.cdc.gov/hiv/capacity-building-assistance/</ext-link>. Accessed <date-in-citation>September 9, 2024</date-in-citation>.</mixed-citation></ref><ref id="R32"><label>32.</label><mixed-citation publication-type="webpage"><collab>Centers for Disease Control and Prevention</collab>. <source>Individual-level social determinants of health and quality of life among persons with diagnosed HIV infection&#x02014;Medical Monitoring Project, United States, 2021 Data Cycle (June 2021&#x02013;May 2022)</source>. Available at: <ext-link xlink:href="https://www.cdc.gov/hiv/library/reports/hiv-surveillance.html" ext-link-type="uri">https://www.cdc.gov/hiv/library/reports/hiv-surveillance.html</ext-link>. Accessed <date-in-citation>July 29, 2024</date-in-citation>.</mixed-citation></ref><ref id="R33"><label>33.</label><mixed-citation publication-type="journal"><name><surname>Carey</surname><given-names>JW</given-names></name>, <name><surname>Roland</surname><given-names>KB</given-names></name>, <name><surname>Bessler</surname><given-names>PA</given-names></name>, <etal/>
<article-title>Overcoming challenges to HIV medical care-seeking and treatment among data-to-care program clients in Baton Rouge and New Orleans, Louisiana</article-title>. <source>J Assoc Nurses AIDS Care</source>. <year>2023</year>;<volume>34</volume>:<fpage>71</fpage>&#x02013;<lpage>82</lpage>.<pub-id pub-id-type="pmid">36524875</pub-id>
</mixed-citation></ref><ref id="R34"><label>34.</label><mixed-citation publication-type="journal"><name><surname>Roland</surname><given-names>KB</given-names></name>, <name><surname>Carey</surname><given-names>JW</given-names></name>, <name><surname>Bessler</surname><given-names>PA</given-names></name>, <etal/>
<article-title>&#x0201c;Take care of their hierarchy of needs first&#x0201d;: strategies used by data-to-care staff to address barriers to HIV care engagement</article-title>. <source>AIDS Care</source>. <year>2023</year>;<volume>35</volume>:<fpage>764</fpage>&#x02013;<lpage>771</lpage>.<pub-id pub-id-type="pmid">35611755</pub-id>
</mixed-citation></ref></ref-list></back><floats-group><table-wrap position="float" id="T1" orientation="landscape"><label>TABLE 1.</label><caption><p id="P28">Barriers to Rapid Enrollment and Documents Required for Scheduling First Appointment at HIV Care Facilities Attended by People With Diagnosed HIV, Overall and by RWHAP Facility Funding Status and by Number of Business Days to Offering First Appointments&#x02014;Medical Monitoring Project, United States, 2021</p></caption><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/></colgroup><thead><tr><th align="center" valign="top" rowspan="1" colspan="1"/><th colspan="10" align="center" valign="bottom" rowspan="1"/><th colspan="9" align="center" valign="bottom" style="border-bottom: solid 1px" rowspan="1">Facilities at Which New Patients are Routinely Offered an Appointment With an HIV Care Provider in</th></tr><tr><th align="center" valign="top" rowspan="1" colspan="1"/><th colspan="3" align="center" valign="bottom" style="border-bottom: solid 1px" rowspan="1">All Facilities</th><th colspan="3" align="center" valign="bottom" style="border-bottom: solid 1px" rowspan="1">RWHAP Funded</th><th colspan="3" align="center" valign="bottom" style="border-bottom: solid 1px" rowspan="1">RWHAP Nonfunded</th><th align="center" valign="bottom" rowspan="1" colspan="1"/><th colspan="3" align="center" valign="bottom" style="border-bottom: solid 1px" rowspan="1">&#x02264;1 Business day</th><th colspan="3" align="center" valign="bottom" style="border-bottom: solid 1px" rowspan="1">2&#x02013;9 Business days</th><th colspan="3" align="center" valign="bottom" style="border-bottom: solid 1px" rowspan="1">&#x02265;10 Business days</th></tr><tr><th align="center" valign="top" rowspan="1" colspan="1"/><th align="center" valign="bottom" rowspan="1" colspan="1">N</th><th align="center" valign="bottom" rowspan="1" colspan="1">Weighted Col%</th><th align="center" valign="bottom" rowspan="1" colspan="1">95%CI</th><th align="center" valign="bottom" rowspan="1" colspan="1">N</th><th align="center" valign="bottom" rowspan="1" colspan="1">Weighted Col%</th><th align="center" valign="bottom" rowspan="1" colspan="1">95%CI</th><th align="center" valign="bottom" rowspan="1" colspan="1">N</th><th align="center" valign="bottom" rowspan="1" colspan="1">Weighted Col%</th><th align="center" valign="bottom" rowspan="1" colspan="1">95%CI</th><th align="center" valign="bottom" rowspan="1" colspan="1">Rao Scott<break/>&#x003c7;<sup>2</sup><break/><italic toggle="yes">P</italic></th><th align="center" valign="bottom" rowspan="1" colspan="1">N</th><th align="center" valign="bottom" rowspan="1" colspan="1">Weighted Col%</th><th align="center" valign="bottom" rowspan="1" colspan="1">95% CI</th><th align="center" valign="bottom" rowspan="1" colspan="1">N</th><th align="center" valign="bottom" rowspan="1" colspan="1">Weighted Col%</th><th align="center" valign="bottom" rowspan="1" colspan="1">95%CI</th><th align="center" valign="bottom" rowspan="1" colspan="1">N</th><th align="center" valign="bottom" rowspan="1" colspan="1">Weighted Col%</th><th align="center" valign="bottom" rowspan="1" colspan="1">95%CI</th></tr></thead><tbody><tr><td align="left" valign="top" rowspan="1" colspan="1">Total (row)</td><td align="center" valign="top" rowspan="1" colspan="1">455</td><td align="center" valign="top" rowspan="1" colspan="1">-</td><td align="center" valign="top" rowspan="1" colspan="1">-</td><td align="center" valign="top" rowspan="1" colspan="1">257</td><td align="center" valign="top" rowspan="1" colspan="1">43.1</td><td align="center" valign="top" rowspan="1" colspan="1">38.4 to 47.7</td><td align="center" valign="top" rowspan="1" colspan="1">198</td><td align="center" valign="top" rowspan="1" colspan="1">56.9</td><td align="center" valign="top" rowspan="1" colspan="1">52.3 to 61.6</td><td align="center" valign="top" rowspan="1" colspan="1">-</td><td align="center" valign="top" rowspan="1" colspan="1">89</td><td align="center" valign="top" rowspan="1" colspan="1">19.9</td><td align="center" valign="top" rowspan="1" colspan="1">16.0 to 23.9</td><td align="center" valign="top" rowspan="1" colspan="1">217</td><td align="center" valign="top" rowspan="1" colspan="1">48.4</td><td align="center" valign="top" rowspan="1" colspan="1">43.4 to 53.4</td><td align="center" valign="top" rowspan="1" colspan="1">128</td><td align="center" valign="top" rowspan="1" colspan="1">31.6</td><td align="center" valign="top" rowspan="1" colspan="1">27.0 to 36.3</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Barrier</td><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;Patient preference</td><td align="center" valign="top" rowspan="1" colspan="1">217</td><td align="center" valign="top" rowspan="1" colspan="1">50.4</td><td align="center" valign="top" rowspan="1" colspan="1">45.3 to 55.5</td><td align="center" valign="top" rowspan="1" colspan="1">139</td><td align="center" valign="top" rowspan="1" colspan="1">58.8</td><td align="center" valign="top" rowspan="1" colspan="1">52.1 to 65.4</td><td align="center" valign="top" rowspan="1" colspan="1">78</td><td align="center" valign="top" rowspan="1" colspan="1">43.8</td><td align="center" valign="top" rowspan="1" colspan="1">36.5 to 51.1</td><td align="center" valign="top" rowspan="1" colspan="1">0.003</td><td align="center" valign="top" rowspan="1" colspan="1">52</td><td align="center" valign="top" rowspan="1" colspan="1">64.9</td><td align="center" valign="top" rowspan="1" colspan="1">53.5 to 76.4</td><td align="center" valign="top" rowspan="1" colspan="1">115</td><td align="center" valign="top" rowspan="1" colspan="1">55.9</td><td align="center" valign="top" rowspan="1" colspan="1">48.6 to 63.1</td><td align="center" valign="top" rowspan="1" colspan="1">49</td><td align="center" valign="top" rowspan="1" colspan="1">37.1</td><td align="center" valign="top" rowspan="1" colspan="1">28.4 to 45.9</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;Insufficient provider capacity to see rapid entry patients</td><td align="center" valign="top" rowspan="1" colspan="1">223</td><td align="center" valign="top" rowspan="1" colspan="1">55.5</td><td align="center" valign="top" rowspan="1" colspan="1">50.5 to 60.5</td><td align="center" valign="top" rowspan="1" colspan="1">113</td><td align="center" valign="top" rowspan="1" colspan="1">47.5</td><td align="center" valign="top" rowspan="1" colspan="1">40.8 to 54.2</td><td align="center" valign="top" rowspan="1" colspan="1">110</td><td align="center" valign="top" rowspan="1" colspan="1">61.8</td><td align="center" valign="top" rowspan="1" colspan="1">54.6 to 69.0</td><td align="center" valign="top" rowspan="1" colspan="1">0.005</td><td align="center" valign="top" rowspan="1" colspan="1">17</td><td align="center" valign="top" rowspan="1" colspan="1">24</td><td align="center" valign="top" rowspan="1" colspan="1">13.6 to 34.5</td><td align="center" valign="top" rowspan="1" colspan="1">105</td><td align="center" valign="top" rowspan="1" colspan="1">52</td><td align="center" valign="top" rowspan="1" colspan="1">44.8 to 59.3</td><td align="center" valign="top" rowspan="1" colspan="1">96</td><td align="center" valign="top" rowspan="1" colspan="1">77</td><td align="center" valign="top" rowspan="1" colspan="1">69.4 to 84.6</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;Patients lack documents required for facility enrollment</td><td align="center" valign="top" rowspan="1" colspan="1">83</td><td align="center" valign="top" rowspan="1" colspan="1">18.6</td><td align="center" valign="top" rowspan="1" colspan="1">14.7 to 22.5</td><td align="center" valign="top" rowspan="1" colspan="1">52</td><td align="center" valign="top" rowspan="1" colspan="1">20</td><td align="center" valign="top" rowspan="1" colspan="1">14.8 to 25.3</td><td align="center" valign="top" rowspan="1" colspan="1">31</td><td align="center" valign="top" rowspan="1" colspan="1">17.4</td><td align="center" valign="top" rowspan="1" colspan="1">11.8 to 23.0</td><td align="center" valign="top" rowspan="1" colspan="1">0.505</td><td align="center" valign="top" rowspan="1" colspan="1">13</td><td align="center" valign="top" rowspan="1" colspan="1">17.3</td><td align="center" valign="top" rowspan="1" colspan="1">8.2 to 26.4</td><td align="center" valign="top" rowspan="1" colspan="1">42</td><td align="center" valign="top" rowspan="1" colspan="1">19.5</td><td align="center" valign="top" rowspan="1" colspan="1">13.8 to 25.2</td><td align="center" valign="top" rowspan="1" colspan="1">26</td><td align="center" valign="top" rowspan="1" colspan="1">17.7</td><td align="center" valign="top" rowspan="1" colspan="1">10.9 to 24.4</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;Patients lack documents required for ryan white HIV/AIDS program enrollment</td><td align="center" valign="top" rowspan="1" colspan="1">69</td><td align="center" valign="top" rowspan="1" colspan="1">12.1</td><td align="center" valign="top" rowspan="1" colspan="1">9.1 to 15.0</td><td align="center" valign="top" rowspan="1" colspan="1">65</td><td align="center" valign="top" rowspan="1" colspan="1">24.6</td><td align="center" valign="top" rowspan="1" colspan="1">18.9 to 30.2</td><td align="center" valign="top" rowspan="1" colspan="1">4</td><td align="center" valign="top" rowspan="1" colspan="1">2.2<xref rid="TFN2" ref-type="table-fn">*</xref></td><td align="center" valign="top" rowspan="1" colspan="1">0.1 to 4.4<xref rid="TFN2" ref-type="table-fn">*</xref></td><td align="center" valign="top" rowspan="1" colspan="1">&#x0003c;0.0001<xref rid="TFN2" ref-type="table-fn">*</xref></td><td align="center" valign="top" rowspan="1" colspan="1">8</td><td align="center" valign="top" rowspan="1" colspan="1">6.9<xref rid="TFN2" ref-type="table-fn">*</xref>,<xref rid="TFN3" ref-type="table-fn">&#x02020;</xref></td><td align="center" valign="top" rowspan="1" colspan="1">(1.8 to 11.9)<xref rid="TFN2" ref-type="table-fn">*</xref>,<xref rid="TFN3" ref-type="table-fn">&#x02020;</xref></td><td align="center" valign="top" rowspan="1" colspan="1">39</td><td align="center" valign="top" rowspan="1" colspan="1">13.7</td><td align="center" valign="top" rowspan="1" colspan="1">9.3 to 18.1</td><td align="center" valign="top" rowspan="1" colspan="1">21</td><td align="center" valign="top" rowspan="1" colspan="1">12.8</td><td align="center" valign="top" rowspan="1" colspan="1">7.2 to 18.4</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;Facility administration is not committed to rapid enrollment</td><td align="center" valign="top" rowspan="1" colspan="1">10</td><td align="center" valign="top" rowspan="1" colspan="1">2.6<xref rid="TFN2" ref-type="table-fn">*</xref></td><td align="center" valign="top" rowspan="1" colspan="1">1.0 to 4.3<xref rid="TFN2" ref-type="table-fn">*</xref></td><td align="center" valign="top" rowspan="1" colspan="1">5</td><td align="center" valign="top" rowspan="1" colspan="1">2.4<xref rid="TFN2" ref-type="table-fn">*</xref></td><td align="center" valign="top" rowspan="1" colspan="1">0.3 to 4.5<xref rid="TFN2" ref-type="table-fn">*</xref></td><td align="center" valign="top" rowspan="1" colspan="1">5</td><td align="center" valign="top" rowspan="1" colspan="1">2.8<xref rid="TFN2" ref-type="table-fn">*</xref></td><td align="center" valign="top" rowspan="1" colspan="1">0.4 to 5.2<xref rid="TFN2" ref-type="table-fn">*</xref></td><td align="center" valign="top" rowspan="1" colspan="1">0.799<xref rid="TFN2" ref-type="table-fn">*</xref></td><td align="center" valign="top" rowspan="1" colspan="1">1</td><td align="center" valign="top" rowspan="1" colspan="1">1.8<xref rid="TFN2" ref-type="table-fn">*</xref>,<xref rid="TFN3" ref-type="table-fn">&#x02020;</xref></td><td align="center" valign="top" rowspan="1" colspan="1">(0.0 to 5.3)<xref rid="TFN2" ref-type="table-fn">*</xref>,<xref rid="TFN3" ref-type="table-fn">&#x02020;</xref></td><td align="center" valign="top" rowspan="1" colspan="1">4</td><td align="center" valign="top" rowspan="1" colspan="1">2.3<xref rid="TFN2" ref-type="table-fn">*</xref></td><td align="center" valign="top" rowspan="1" colspan="1">0.0 to 4.5<xref rid="TFN2" ref-type="table-fn">*</xref></td><td align="center" valign="top" rowspan="1" colspan="1">4</td><td align="center" valign="top" rowspan="1" colspan="1">2.8<xref rid="TFN2" ref-type="table-fn">*</xref>,<xref rid="TFN3" ref-type="table-fn">&#x02020;</xref></td><td align="center" valign="top" rowspan="1" colspan="1">(0.0 to 5.6)<xref rid="TFN2" ref-type="table-fn">*</xref>,<xref rid="TFN3" ref-type="table-fn">&#x02020;</xref></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;Other staff are not committed to rapid enrollment</td><td align="center" valign="top" rowspan="1" colspan="1">8</td><td align="center" valign="top" rowspan="1" colspan="1">1.6<xref rid="TFN2" ref-type="table-fn">*</xref></td><td align="center" valign="top" rowspan="1" colspan="1">0.4 to 2.7<xref rid="TFN2" ref-type="table-fn">*</xref></td><td align="center" valign="top" rowspan="1" colspan="1">7</td><td align="center" valign="top" rowspan="1" colspan="1">2.9<xref rid="TFN2" ref-type="table-fn">*</xref></td><td align="center" valign="top" rowspan="1" colspan="1">0.7 to 5.1<xref rid="TFN2" ref-type="table-fn">*</xref></td><td align="center" valign="top" rowspan="1" colspan="1">1</td><td align="center" valign="top" rowspan="1" colspan="1">0.6<xref rid="TFN2" ref-type="table-fn">*</xref></td><td align="center" valign="top" rowspan="1" colspan="1">0.0 to 1.7<xref rid="TFN2" ref-type="table-fn">*</xref></td><td align="center" valign="top" rowspan="1" colspan="1">0.087<xref rid="TFN2" ref-type="table-fn">*</xref></td><td align="center" valign="top" rowspan="1" colspan="1">1</td><td align="center" valign="top" rowspan="1" colspan="1">1.8<xref rid="TFN2" ref-type="table-fn">*</xref>,<xref rid="TFN3" ref-type="table-fn">&#x02020;</xref></td><td align="center" valign="top" rowspan="1" colspan="1">0.0 to 5.3)<xref rid="TFN2" ref-type="table-fn">*</xref>,<xref rid="TFN3" ref-type="table-fn">&#x02020;</xref></td><td align="center" valign="top" rowspan="1" colspan="1">5</td><td align="center" valign="top" rowspan="1" colspan="1">1.8<xref rid="TFN2" ref-type="table-fn">*</xref></td><td align="center" valign="top" rowspan="1" colspan="1">0.1 to 3.5<xref rid="TFN2" ref-type="table-fn">*</xref></td><td align="center" valign="top" rowspan="1" colspan="1">2</td><td align="center" valign="top" rowspan="1" colspan="1">1.2<xref rid="TFN2" ref-type="table-fn">*</xref></td><td align="center" valign="top" rowspan="1" colspan="1">0.0 to 2.9)<xref rid="TFN2" ref-type="table-fn">*</xref></td></tr><tr><td colspan="20" align="left" valign="top" rowspan="1">Documents required for scheduling the first appointment with an HIV care provider</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;Proof of income</td><td align="center" valign="top" rowspan="1" colspan="1">122</td><td align="center" valign="top" rowspan="1" colspan="1">21.8</td><td align="center" valign="top" rowspan="1" colspan="1">17.9 to 25.6</td><td align="center" valign="top" rowspan="1" colspan="1">110</td><td align="center" valign="top" rowspan="1" colspan="1">41.9</td><td align="center" valign="top" rowspan="1" colspan="1">35.4 to 48.3</td><td align="center" valign="top" rowspan="1" colspan="1">12</td><td align="center" valign="top" rowspan="1" colspan="1">6.3</td><td align="center" valign="top" rowspan="1" colspan="1">2.8 to 9.7</td><td align="center" valign="top" rowspan="1" colspan="1">&#x0003c;0.0001</td><td align="center" valign="top" rowspan="1" colspan="1">20</td><td align="center" valign="top" rowspan="1" colspan="1">15.8</td><td align="center" valign="top" rowspan="1" colspan="1">8.5 to 23.2)</td><td align="center" valign="top" rowspan="1" colspan="1">69</td><td align="center" valign="top" rowspan="1" colspan="1">26.8</td><td align="center" valign="top" rowspan="1" colspan="1">20.7 to 32.8</td><td align="center" valign="top" rowspan="1" colspan="1">32</td><td align="center" valign="top" rowspan="1" colspan="1">19.6</td><td align="center" valign="top" rowspan="1" colspan="1">12.9 to 26.3</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;Proof of residence</td><td align="center" valign="top" rowspan="1" colspan="1">129</td><td align="center" valign="top" rowspan="1" colspan="1">24.1</td><td align="center" valign="top" rowspan="1" colspan="1">20.1 to 28.1</td><td align="center" valign="top" rowspan="1" colspan="1">111</td><td align="center" valign="top" rowspan="1" colspan="1">43.2</td><td align="center" valign="top" rowspan="1" colspan="1">36.6 to 49.7</td><td align="center" valign="top" rowspan="1" colspan="1">18</td><td align="center" valign="top" rowspan="1" colspan="1">9.4</td><td align="center" valign="top" rowspan="1" colspan="1">5.3 to 13.6</td><td align="center" valign="top" rowspan="1" colspan="1">&#x0003c;0.0001</td><td align="center" valign="top" rowspan="1" colspan="1">22</td><td align="center" valign="top" rowspan="1" colspan="1">19.5</td><td align="center" valign="top" rowspan="1" colspan="1">11.2 to 27.8</td><td align="center" valign="top" rowspan="1" colspan="1">71</td><td align="center" valign="top" rowspan="1" colspan="1">28</td><td align="center" valign="top" rowspan="1" colspan="1">21.9 to 34.2</td><td align="center" valign="top" rowspan="1" colspan="1">34</td><td align="center" valign="top" rowspan="1" colspan="1">22.1</td><td align="center" valign="top" rowspan="1" colspan="1">14.9 to 29.2</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;Government&#x02014;issued identification</td><td align="center" valign="top" rowspan="1" colspan="1">164</td><td align="center" valign="top" rowspan="1" colspan="1">35.9</td><td align="center" valign="top" rowspan="1" colspan="1">31.1 to 40.6</td><td align="center" valign="top" rowspan="1" colspan="1">105</td><td align="center" valign="top" rowspan="1" colspan="1">42.3</td><td align="center" valign="top" rowspan="1" colspan="1">35.8 to 48.8</td><td align="center" valign="top" rowspan="1" colspan="1">59</td><td align="center" valign="top" rowspan="1" colspan="1">30.9</td><td align="center" valign="top" rowspan="1" colspan="1">24.3 to 37.5</td><td align="center" valign="top" rowspan="1" colspan="1">0.017</td><td align="center" valign="top" rowspan="1" colspan="1">32</td><td align="center" valign="top" rowspan="1" colspan="1">33.6</td><td align="center" valign="top" rowspan="1" colspan="1">23.2 to 43.9</td><td align="center" valign="top" rowspan="1" colspan="1">77</td><td align="center" valign="top" rowspan="1" colspan="1">35.6</td><td align="center" valign="top" rowspan="1" colspan="1">28.7 to 42.4</td><td align="center" valign="top" rowspan="1" colspan="1">51</td><td align="center" valign="top" rowspan="1" colspan="1">38.2</td><td align="center" valign="top" rowspan="1" colspan="1">29.4 to 47.0</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;Result of a test for tuberculosis (PPD or IGRA)</td><td align="center" valign="top" rowspan="1" colspan="1">28</td><td align="center" valign="top" rowspan="1" colspan="1">5.6</td><td align="center" valign="top" rowspan="1" colspan="1">3.4 to 7.8</td><td align="center" valign="top" rowspan="1" colspan="1">19</td><td align="center" valign="top" rowspan="1" colspan="1">6.8</td><td align="center" valign="top" rowspan="1" colspan="1">3.5 to 10.0</td><td align="center" valign="top" rowspan="1" colspan="1">9</td><td align="center" valign="top" rowspan="1" colspan="1">4.7<xref rid="TFN2" ref-type="table-fn">*</xref></td><td align="center" valign="top" rowspan="1" colspan="1">1.7 to 7.7<xref rid="TFN2" ref-type="table-fn">*</xref></td><td align="center" valign="top" rowspan="1" colspan="1">0.371<xref rid="TFN2" ref-type="table-fn">*</xref></td><td align="center" valign="top" rowspan="1" colspan="1">5</td><td align="center" valign="top" rowspan="1" colspan="1">4.0<xref rid="TFN2" ref-type="table-fn">*</xref>,<xref rid="TFN3" ref-type="table-fn">&#x02020;</xref></td><td align="center" valign="top" rowspan="1" colspan="1">(0.1 to 7.9)<xref rid="TFN2" ref-type="table-fn">*</xref>,<xref rid="TFN3" ref-type="table-fn">&#x02020;</xref></td><td align="center" valign="top" rowspan="1" colspan="1">11</td><td align="center" valign="top" rowspan="1" colspan="1">5.4<xref rid="TFN2" ref-type="table-fn">*</xref></td><td align="center" valign="top" rowspan="1" colspan="1">2.1 to 8.7<xref rid="TFN2" ref-type="table-fn">*</xref></td><td align="center" valign="top" rowspan="1" colspan="1">11</td><td align="center" valign="top" rowspan="1" colspan="1">7.0<xref rid="TFN2" ref-type="table-fn">*</xref></td><td align="center" valign="top" rowspan="1" colspan="1">2.6 to 11.4<xref rid="TFN2" ref-type="table-fn">*</xref></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;Positive HIV antibody or detectable viral load</td><td align="center" valign="top" rowspan="1" colspan="1">247</td><td align="center" valign="top" rowspan="1" colspan="1">51.5</td><td align="center" valign="top" rowspan="1" colspan="1">46.6 to 56.4</td><td align="center" valign="top" rowspan="1" colspan="1">172</td><td align="center" valign="top" rowspan="1" colspan="1">67.4</td><td align="center" valign="top" rowspan="1" colspan="1">61.2 to 73.6</td><td align="center" valign="top" rowspan="1" colspan="1">75</td><td align="center" valign="top" rowspan="1" colspan="1">39.3</td><td align="center" valign="top" rowspan="1" colspan="1">32.3 to 46.2</td><td align="center" valign="top" rowspan="1" colspan="1">&#x0003c;0.0001</td><td align="center" valign="top" rowspan="1" colspan="1">40</td><td align="center" valign="top" rowspan="1" colspan="1">37.3</td><td align="center" valign="top" rowspan="1" colspan="1">26.9 to 47.7</td><td align="center" valign="top" rowspan="1" colspan="1">118</td><td align="center" valign="top" rowspan="1" colspan="1">49.8</td><td align="center" valign="top" rowspan="1" colspan="1">42.6 to 56.9</td><td align="center" valign="top" rowspan="1" colspan="1">81</td><td align="center" valign="top" rowspan="1" colspan="1">61.8</td><td align="center" valign="top" rowspan="1" colspan="1">52.9 to 70.7</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;CD4 lymphocyte count result</td><td align="center" valign="top" rowspan="1" colspan="1">90</td><td align="center" valign="top" rowspan="1" colspan="1">19.2</td><td align="center" valign="top" rowspan="1" colspan="1">15.3 to 23.0</td><td align="center" valign="top" rowspan="1" colspan="1">53</td><td align="center" valign="top" rowspan="1" colspan="1">18.9</td><td align="center" valign="top" rowspan="1" colspan="1">13.9 to 23.9</td><td align="center" valign="top" rowspan="1" colspan="1">37</td><td align="center" valign="top" rowspan="1" colspan="1">19.4</td><td align="center" valign="top" rowspan="1" colspan="1">13.7 to 25.0</td><td align="center" valign="top" rowspan="1" colspan="1">0.902</td><td align="center" valign="top" rowspan="1" colspan="1">12</td><td align="center" valign="top" rowspan="1" colspan="1">9.9<xref rid="TFN2" ref-type="table-fn">*</xref></td><td align="center" valign="top" rowspan="1" colspan="1">4.0 to 15.9<xref rid="TFN2" ref-type="table-fn">*</xref></td><td align="center" valign="top" rowspan="1" colspan="1">37</td><td align="center" valign="top" rowspan="1" colspan="1">15.9</td><td align="center" valign="top" rowspan="1" colspan="1">10.8 to 21.0</td><td align="center" valign="top" rowspan="1" colspan="1">36</td><td align="center" valign="top" rowspan="1" colspan="1">27.7</td><td align="center" valign="top" rowspan="1" colspan="1">19.6 to 35.8</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;None of the above</td><td align="center" valign="top" rowspan="1" colspan="1">134</td><td align="center" valign="top" rowspan="1" colspan="1">32.3</td><td align="center" valign="top" rowspan="1" colspan="1">27.7 to 37.0</td><td align="center" valign="top" rowspan="1" colspan="1">56</td><td align="center" valign="top" rowspan="1" colspan="1">21.3</td><td align="center" valign="top" rowspan="1" colspan="1">16.0 to 26.6</td><td align="center" valign="top" rowspan="1" colspan="1">78</td><td align="center" valign="top" rowspan="1" colspan="1">40.8</td><td align="center" valign="top" rowspan="1" colspan="1">33.8 to 47.8</td><td align="center" valign="top" rowspan="1" colspan="1">&#x0003c;0.0001</td><td align="center" valign="top" rowspan="1" colspan="1">36</td><td align="center" valign="top" rowspan="1" colspan="1">43.9</td><td align="center" valign="top" rowspan="1" colspan="1">32.8 to 55.0</td><td align="center" valign="top" rowspan="1" colspan="1">65</td><td align="center" valign="top" rowspan="1" colspan="1">33.1</td><td align="center" valign="top" rowspan="1" colspan="1">26.3 to 40.0</td><td align="center" valign="top" rowspan="1" colspan="1">29</td><td align="center" valign="top" rowspan="1" colspan="1">23.4</td><td align="center" valign="top" rowspan="1" colspan="1">15.7 to 31.1</td></tr></tbody></table><table-wrap-foot><fn id="TFN1"><p id="P29">Numbers are unweighted, and percentages are weighted.</p></fn><fn id="TFN2"><label>*</label><p id="P30">Estimates with a coefficient of variation &#x02265;0.30 were considered to be unstable and, therefore, should be interpreted with caution; associated statistical testing based on 1 or more unstable estimates should also be interpreted with caution.</p></fn><fn id="TFN3"><label>&#x02020;</label><p id="P31">Estimates with an absolute CI width &#x02265;30, estimates with an absolute CI width between 5 and 30, and a relative CI width &#x0003e;130% should be interpreted with caution.</p></fn></table-wrap-foot></table-wrap><table-wrap position="float" id="T2" orientation="landscape"><label>TABLE 2.</label><caption><p id="P32">Barriers to Obtaining a 30-Day Supply of Antiretroviral Medication on the Day of the First HIV Care Provider Visit Among HIV Care Facilities Attended by People With Diagnosed HIV, Overall and by RWHAP Funding Status&#x02014;Medical Monitoring Project, United States, 2021</p></caption><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/></colgroup><thead><tr><th align="left" valign="top" rowspan="1" colspan="1"/><th colspan="3" align="center" valign="bottom" style="border-bottom: solid 1px" rowspan="1">All Facilities</th><th colspan="3" align="center" valign="bottom" style="border-bottom: solid 1px" rowspan="1">RWHAP Funded</th><th colspan="3" align="center" valign="bottom" style="border-bottom: solid 1px" rowspan="1">RWHAP Nonfunded</th><th rowspan="2" align="center" valign="top" colspan="1">Rao Scott<break/>&#x003c7;<sup>2</sup><break/><italic toggle="yes">P</italic></th></tr><tr><th align="left" valign="bottom" rowspan="1" colspan="1">Barriers</th><th align="center" valign="bottom" rowspan="1" colspan="1">N</th><th align="center" valign="bottom" rowspan="1" colspan="1">Weighted Col%</th><th align="center" valign="bottom" rowspan="1" colspan="1">95% CI</th><th align="center" valign="bottom" rowspan="1" colspan="1">N</th><th align="center" valign="bottom" rowspan="1" colspan="1">Col%</th><th align="center" valign="bottom" rowspan="1" colspan="1">95% CI</th><th align="center" valign="bottom" rowspan="1" colspan="1">N</th><th align="center" valign="bottom" rowspan="1" colspan="1">Col%</th><th align="center" valign="bottom" rowspan="1" colspan="1">95% CI</th></tr></thead><tbody><tr><td align="left" valign="top" rowspan="1" colspan="1">Patient preference</td><td align="center" valign="top" rowspan="1" colspan="1">41</td><td align="center" valign="top" rowspan="1" colspan="1">28.5</td><td align="center" valign="top" rowspan="1" colspan="1">20.7 to 36.4</td><td align="center" valign="top" rowspan="1" colspan="1">18</td><td align="center" valign="top" rowspan="1" colspan="1">23.5</td><td align="center" valign="top" rowspan="1" colspan="1">13.2 to 33.8</td><td align="center" valign="top" rowspan="1" colspan="1">23</td><td align="center" valign="top" rowspan="1" colspan="1">31.1</td><td align="center" valign="top" rowspan="1" colspan="1">20.5 to 41.7</td><td align="center" valign="top" rowspan="1" colspan="1">0.313</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Prescription not given because test results are not available</td><td align="center" valign="top" rowspan="1" colspan="1">81</td><td align="center" valign="top" rowspan="1" colspan="1">55.6</td><td align="center" valign="top" rowspan="1" colspan="1">46.9 to 64.3</td><td align="center" valign="top" rowspan="1" colspan="1">43</td><td align="center" valign="top" rowspan="1" colspan="1">63.9</td><td align="center" valign="top" rowspan="1" colspan="1">51.7 to 76.0</td><td align="center" valign="top" rowspan="1" colspan="1">38</td><td align="center" valign="top" rowspan="1" colspan="1">51.4</td><td align="center" valign="top" rowspan="1" colspan="1">39.9 to 62.8</td><td align="center" valign="top" rowspan="1" colspan="1">0.143</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Delay getting medication paid for</td><td align="center" valign="top" rowspan="1" colspan="1">65</td><td align="center" valign="top" rowspan="1" colspan="1">48.7</td><td align="center" valign="top" rowspan="1" colspan="1">40.0 to 57.4</td><td align="center" valign="top" rowspan="1" colspan="1">25</td><td align="center" valign="top" rowspan="1" colspan="1">38.3</td><td align="center" valign="top" rowspan="1" colspan="1">25.9 to 50.6</td><td align="center" valign="top" rowspan="1" colspan="1">40</td><td align="center" valign="top" rowspan="1" colspan="1">54.1</td><td align="center" valign="top" rowspan="1" colspan="1">42.7 to 65.5</td><td align="center" valign="top" rowspan="1" colspan="1">0.069</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Antiretroviral starter packs are not available to be given to patients</td><td align="center" valign="top" rowspan="1" colspan="1">52</td><td align="center" valign="top" rowspan="1" colspan="1">35.9</td><td align="center" valign="top" rowspan="1" colspan="1">27.6 to 44.2</td><td align="center" valign="top" rowspan="1" colspan="1">25</td><td align="center" valign="top" rowspan="1" colspan="1">34.8</td><td align="center" valign="top" rowspan="1" colspan="1">22.9 to 46.7</td><td align="center" valign="top" rowspan="1" colspan="1">27</td><td align="center" valign="top" rowspan="1" colspan="1">36.5</td><td align="center" valign="top" rowspan="1" colspan="1">25.5 to 47.5</td><td align="center" valign="top" rowspan="1" colspan="1">0.838</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Lack of trained staff to submit patient assistance program applications for free antiretrovirals</td><td align="center" valign="top" rowspan="1" colspan="1">10</td><td align="center" valign="top" rowspan="1" colspan="1">8.6</td><td align="center" valign="top" rowspan="1" colspan="1">3.5 to 13.7</td><td align="center" valign="top" rowspan="1" colspan="1">1</td><td align="center" valign="top" rowspan="1" colspan="1">1.6<xref rid="TFN5" ref-type="table-fn">*</xref></td><td align="center" valign="top" rowspan="1" colspan="1">0.0 to 4.8<xref rid="TFN5" ref-type="table-fn">*</xref></td><td align="center" valign="top" rowspan="1" colspan="1">9</td><td align="center" valign="top" rowspan="1" colspan="1">12.2<xref rid="TFN5" ref-type="table-fn">*</xref></td><td align="center" valign="top" rowspan="1" colspan="1">4.7 to 19.6<xref rid="TFN5" ref-type="table-fn">*</xref></td><td align="center" valign="top" rowspan="1" colspan="1">0.02<xref rid="TFN5" ref-type="table-fn">*</xref></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Patient cannot afford copayment</td><td align="center" valign="top" rowspan="1" colspan="1">41</td><td align="center" valign="top" rowspan="1" colspan="1">30.7</td><td align="center" valign="top" rowspan="1" colspan="1">22.6 to 38.8</td><td align="center" valign="top" rowspan="1" colspan="1">13</td><td align="center" valign="top" rowspan="1" colspan="1">16.8</td><td align="center" valign="top" rowspan="1" colspan="1">7.8 to 25.8</td><td align="center" valign="top" rowspan="1" colspan="1">28</td><td align="center" valign="top" rowspan="1" colspan="1">37.8</td><td align="center" valign="top" rowspan="1" colspan="1">26.7 to 48.9</td><td align="center" valign="top" rowspan="1" colspan="1">0.005</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Providers are not committed to immediate antiretroviral initiation</td><td align="center" valign="top" rowspan="1" colspan="1">16</td><td align="center" valign="top" rowspan="1" colspan="1">11.8</td><td align="center" valign="top" rowspan="1" colspan="1">6.1 to 17.4</td><td align="center" valign="top" rowspan="1" colspan="1">6</td><td align="center" valign="top" rowspan="1" colspan="1">8.4<xref rid="TFN5" ref-type="table-fn">*</xref>,<xref rid="TFN6" ref-type="table-fn">&#x02020;</xref></td><td align="center" valign="top" rowspan="1" colspan="1">(1.7 to 15.0)<xref rid="TFN5" ref-type="table-fn">*</xref>,<xref rid="TFN6" ref-type="table-fn">&#x02020;</xref></td><td align="center" valign="top" rowspan="1" colspan="1">10</td><td align="center" valign="top" rowspan="1" colspan="1">13.5</td><td align="center" valign="top" rowspan="1" colspan="1">5.7 to 21.3</td><td align="center" valign="top" rowspan="1" colspan="1">0.328<xref rid="TFN5" ref-type="table-fn">*</xref>,<xref rid="TFN6" ref-type="table-fn">&#x02020;</xref></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Facility administration is not committed to immediate antiretroviral initiation</td><td align="center" valign="top" rowspan="1" colspan="1">7</td><td align="center" valign="top" rowspan="1" colspan="1">4.4</td><td align="center" valign="top" rowspan="1" colspan="1">1.0 to 7.8</td><td align="center" valign="top" rowspan="1" colspan="1">4</td><td align="center" valign="top" rowspan="1" colspan="1">5.1<xref rid="TFN5" ref-type="table-fn">*</xref>,<xref rid="TFN6" ref-type="table-fn">&#x02020;</xref></td><td align="center" valign="top" rowspan="1" colspan="1">(0.0 to 10.2)<xref rid="TFN5" ref-type="table-fn">*</xref>,<xref rid="TFN6" ref-type="table-fn">&#x02020;</xref></td><td align="center" valign="top" rowspan="1" colspan="1">3</td><td align="center" valign="top" rowspan="1" colspan="1">4.1<xref rid="TFN5" ref-type="table-fn">*</xref>,<xref rid="TFN6" ref-type="table-fn">&#x02020;</xref></td><td align="center" valign="top" rowspan="1" colspan="1">(0.0 to 8.6)<xref rid="TFN5" ref-type="table-fn">*</xref>,<xref rid="TFN6" ref-type="table-fn">&#x02020;</xref></td><td align="center" valign="top" rowspan="1" colspan="1">0.767<xref rid="TFN5" ref-type="table-fn">*</xref>,<xref rid="TFN6" ref-type="table-fn">&#x02020;</xref></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Lack of a standardized protocol for all clinicians to follow</td><td align="center" valign="top" rowspan="1" colspan="1">14</td><td align="center" valign="top" rowspan="1" colspan="1">10.2</td><td align="center" valign="top" rowspan="1" colspan="1">4.9 to 15.5</td><td align="center" valign="top" rowspan="1" colspan="1">6</td><td align="center" valign="top" rowspan="1" colspan="1">9.0<xref rid="TFN5" ref-type="table-fn">*</xref>,<xref rid="TFN6" ref-type="table-fn">&#x02020;</xref></td><td align="center" valign="top" rowspan="1" colspan="1">(1.8 to 16.3)<xref rid="TFN5" ref-type="table-fn">*</xref>,<xref rid="TFN6" ref-type="table-fn">&#x02020;</xref></td><td align="center" valign="top" rowspan="1" colspan="1">8</td><td align="center" valign="top" rowspan="1" colspan="1">10.8<xref rid="TFN5" ref-type="table-fn">*</xref>,<xref rid="TFN6" ref-type="table-fn">&#x02020;</xref></td><td align="center" valign="top" rowspan="1" colspan="1">(3.7 to 17.9)<xref rid="TFN5" ref-type="table-fn">*</xref>,<xref rid="TFN6" ref-type="table-fn">&#x02020;</xref></td><td align="center" valign="top" rowspan="1" colspan="1">0.729<xref rid="TFN5" ref-type="table-fn">*</xref>,<xref rid="TFN6" ref-type="table-fn">&#x02020;</xref></td></tr></tbody></table><table-wrap-foot><fn id="TFN4"><p id="P33">Numbers are unweighted, and percentages are weighted.</p></fn><fn id="TFN5"><label>*</label><p id="P34">Estimates with a coefficient of variation &#x02265;0.30 were considered to be unstable and, therefore, should be interpreted with caution; associated statistical testing based on 1 or more unstable estimates should also be interpreted with caution.</p></fn><fn id="TFN6"><label>&#x02020;</label><p id="P35">Estimates with an absolute CI width &#x02265;30, estimates with an absolute CI width between 5 and 30, and a relative CI width .130% should be interpreted with caution.</p></fn></table-wrap-foot></table-wrap></floats-group></article>